Kosin has over 10 years of accumulation and experience in the field of organic synthesis, and has built an international level drug small molecule customization service platform. It provides efficient, flexible, and high-quality customized development services for every stage of drug research and development organizations worldwide before their launch.

Our core technology team has extensive experience in pharmaceutical companies in Japan and Germany, and has demonstrated outstanding performance in research and development, technology amplification, technology transfer, and optimization of innovation and drug development.

Our self-developed products include DBCO reagents, OLED electroluminescent materials, and various widely used organic synthetic building blocks.